SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-15-214226
Filing Date
2015-06-05
Accepted
2015-06-05 09:11:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d935452dsc13ga.htm SC 13G/A 28962
  Complete submission text file 0001193125-15-214226.txt   30902
Mailing Address 227 W MONROE ST STE 3000 CHICAGO IL 60606
Business Address 227 W MONROE STREET SUITE 3000 CHICAGO IL 60606 312-634-9200
COLUMBIA WANGER ASSET MANAGEMENT LLC (Filed by) CIK: 0000908733 (see all company filings)

IRS No.: 043519872 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Subject) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-52299 | Film No.: 15914540
SIC: 2836 Biological Products, (No Diagnostic Substances)